Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer von SPIGEL, David R, ERVIN, Thomas J, GOVINDAN, Ramaswamy, PATEL, Taral, ORLOV, Sergey V, WERTHEIM, Michael S, WEI YU, JIPING ZHA, YAUCH, Robert L, PATEL, Premal H, PHAN, See-Chun, PETERSON, Amy C, RAMLAU, Rodryg A, DANIEL, Davey B, GOLDSCHMIDT, Jerome H, BLUMENSCHEIN, George R, KRZAKOWSKI, Maciej J, ROBINET, Gilles, GODBERT, Benoit, BARLESI, Fabrice

Volltext

Parsaclisib, a potent and highly selective PI3Kδ inhibitor, in patients with relapsed or refractory B-cell malignancies von Forero-Torres, Andres, Ramchandren, Radhakrishnan, Yacoub, Abdulraheem, Wertheim, Michael S., Edenfield, William J., Caimi, Paolo, Gutierrez, Martin, Akard, Luke, Escobar, Carolina, Call, Justin, Persky, Daniel, Iyer, Swaminathan, DeMarini, Douglas J., Zhou, Li, Chen, Xuejun, Dawkins, Fitzroy, Phillips, Tycel J.

Volltext

Safety and Immunogenicity of Heat-Treated Zoster Vaccine (ZVHT) in Immunocompromised Adults von Mullane, Kathleen M., Winston, Drew J., Wertheim, Michael S., Betts, Robert F., Poretz, Donald M., Camacho, Luis H., Pergam, Steven A., Mullane, Michael R., Stek, Jon E., Sterling, Tina M., Zhao, Yanli, Manoff, Susan B., Annunziato, Paula W.

Volltext

Bintrafusp Alfa: A Bifunctional Fusion Protein Targeting PD-L1 and TGF-β, in Patients with Pretreated Colorectal Cancer: Results from a Phase I Trial von Spira, Alexander, Wertheim, Michael S, Kim, Edward J, Tan, Benjamin, Lenz, Heinz-Josef, Nikolinakos, Petros, Rich, Patricia L, Jehl, Genevieve, Machl, Andreas, Ito, Rena, Gulley, James L, Kopetz, Scott

Volltext

Phase I/II Study of Pemetrexed With or Without ABT-751 in Advanced or Metastatic Non–Small-Cell Lung Cancer von RUDIN, Charles M, MAUER, Ann, JANE QIAN, PRADHAN, Rajendra, DOWELL, Barry, KRIVOSHIK, Andrew, GORDON, Gary, SMAKAL, Martin, JUERGENS, Rosalyn, SPELDA, Stanislav, WERTHEIM, Michael, COATES, Andrew, MCKEEGAN, Evelyn, ANSELL, Peter, XIANGDONG ZHOU

Volltext

The Clinical Time-Course of Experimental Autoimmune Uveoretinitis Using Topical Endoscopic Fundal Imaging with Histologic and Cellular Infiltrate Correlation von Copland, David A, Wertheim, Michael S, Armitage, W. John, Nicholson, Lindsay B, Raveney, Ben J. E, Dick, Andrew D

Volltext

Phase II Study of the Multitargeted Tyrosine Kinase Inhibitor XL647 in Patients with Non–Small-Cell Lung Cancer von Pietanza, M. Catherine, Gadgeel, Shirish M., Dowlati, Afshin, Lynch, Thomas J., Salgia, Ravi, Rowland, Kendrith M., Wertheim, Michael S., Price, Katharine A., Riely, Gregory J., Azzoli, Christopher G., Miller, Vincent A., Krug, Lee M., Kris, Mark G., Beumer, Jan H., Tonda, Margaret, Mitchell, Ben, Rizvi, Naiyer A.

Volltext

Randomized Multicenter Phase II Trial of Bolus Plus Infusional Fluorouracil/Leucovorin Compared With Fluorouracil/Leucovorin Plus Oxaliplatin As Third-Line Treatment of Patients Wi... von KEMENY, Nancy, GARAY, Carlos A, HALLMAN, Doreen, BURGER, Brent, GUPTA, Sunil, GURTLER, Jayne, HOCHSTER, Howard, KENNEDY, Peter, BENSON, Al, BRANDT, Debra Schwab, POLIKOFF, Jonathan, WERTHEIM, Michael, SHUMAKER, Grace

Volltext

Long-Term Follow-Up of Patients with Birdshot Retinochoroidopathy Treated with Systemic Immunosuppression von Becker, Matthias D., Wertheim, Michael S., Smith, Justine R., Rosenbaum, James T.

Volltext

A Prospective Trial of Infliximab Therapy for Refractory Uveitis: Preliminary Safety and Efficacy Outcomes von Suhler, Eric B, Smith, Justine R, Wertheim, Michael S, Lauer, Andreas K, Kurz, Daryl E, Pickard, Terri D, Rosenbaum, James T

Volltext

Analysis of the Diurnal Intraocular Pressure Profile Pre and Post Trabeculectomy using 24-Hour Monitoring of Intraocular Pressure von Ross, Adam H., Jackson, Thomas E., Wertheim, Michael S., Spry, Paul G.D., Sparrow, John M., Diamond, Jeremy P.

Volltext

Bintrafusp Alfa: A Bifunctional Fusion Protein Targeting PD-L1 and TGF- [beta], in Patients with Pretreated Colorectal Cancer: Results from a Phase I Trial von Spira, Alexander, Wertheim, Michael S, Kim, Edward J, Tan, Benjamin, Lenz, Heinz-Josef, Nikolinakos, Petros, Rich, Patricia L, Jehl, Genevieve, Machl, Andreas, Ito, Rena, Gulley, James L, Kopetz, Scott

Volltext

Electrolysis-Needle Cauterization of Corneal Vessels in Patients With Lipid Keratopathy von Wertheim, Michael S, Cook, Stuart D, Knox-Cartwright, Nathaniel E, Van, Dung Le, Tole, Derek M

Volltext

Non-Invasive Detection of Multinucleated Giant Cells in the Conjunctiva of Patients with Sarcoidosis by In-Vivo Confocal Microscopy von Wertheim, Michael S., Mathers, William D., Lim, Lyndell, Watkins, Angela S., Mackensen, Friederike, O'Malley, Jean P., Rosenbaum, James T.

Volltext

M7824 (MSB0011359C), a bifunctional fusion protein targeting PD-L1 and TGF-β, in patients with heavily pretreated CRC: Preliminary results from a phase I trial von Kopetz, Scott, Spira, Alexander I., Wertheim, Michael, Kim, Edward, Tan, Benjamin R., Lenz, Heinz-Josef, Nikolinakos, Petros, Rich, Patricia, Smith, David A., Helwig, Christoph, Dussault, Isabelle, Ojalvo, Laureen, Gulley, James L.

Volltext

Results from a Phase 1/2 Study of INCB050465, a Highly Selective and Highly Potent PI3Kδ Inhibitor, in Patients with Relapsed or Refractory B-Cell Malignancies (CITADEL-101) von Forero-Torres, Andres, Ramchandren, Rod, Yacoub, Abdulraheem, Wertheim, Michael S., Edenfield, William J., Caimi, Paolo, Gutierrez, Martin, Akard, Luke, Escobar, Carolina, Call, Justin, Persky, Daniel, Iyer, Swami P., DeMarini, Douglas J., Zhou, Li, Yeleswaram, Swamy, Phillips, Tycel J.

Volltext

Ongoing phase 1/2 study of INCB050465 for relapsed/refractory (R/R) B-cell malignancies (CITADEL-101) von Ramchandren, Rod, Phillips, Tycel Jovelle, Wertheim, Michael, Gutierrez, Martin, Edenfield, William Jeffery, Akard, Luke Paul, Caimi, Paolo Fabrizio, Call, Justin, Persky, Daniel Oscar, DeMarini, Douglas James, Zhou, Li, Yeleswaram, Swamy, Forero-Torres, Andres

Volltext

An Ongoing Open-Label Phase 1/2 Study of INCB050465, a Selective PI3Kδ Inhibitor, in Patients with Previously Treated B-Cell Malignancies von Phillips, Tycel, Ramchandren, Rod, Wertheim, Michael S, Gutierrez, Martin E, Edenfield, William J, Dawkins, Fitzroy, DeMarini, Doug J, Zhou, Li, Yeleswaram, Swamy, Newton, Robert C, Chen, Xuejun, Forero-Torres, Andres

Volltext

Abstract CT056: Preliminary safety, efficacy, and pharmacodynamics of a highly selective PI3K inhibitor, INCB050465, in patients with previously treated B-cell malignancies von ero-Torres, Andres, Wertheim, Michael S, Phillips, Tycel J, Gutierrez, Martin E, Edenfield, William J, Yeleswaram, Swamy, Bleam, Maureen, Zhou, Li, Pulini, Jennifer H, Faivre, Tha, Miao, Harry, Spear, Matt, Ramchandren, Rod

Volltext

Abstract CT056: Preliminary safety, efficacy, and pharmacodynamics of a highly selective PI3Kδ inhibitor, INCB050465, in patients with previously treated B-cell malignancies von Forero-Torres, Andres, Wertheim, Michael S., Phillips, Tycel J., Gutierrez, Martin E., Edenfield, William J., Yeleswaram, Swamy, Bleam, Maureen, Zhou, Li, Pulini, Jennifer H., Faivre, Théa, Miao, Harry, Spear, Matt, Ramchandren, Rod

Volltext